VIEWS: 14 PAGES: 2 CATEGORY: Medicine POSTED ON: 6/26/2010
A global leader in serving libraries of all types, ProQuest LLC (“ProQuest”) supports the breadth of the information community with innovative discovery solutions that power the business of books and the best in research experience. More than a content provider or aggregator, ProQuest is an information partner, creating indispensable research solutions that connect people and information. Through innovative, user-centered discovery technology, ProQuest offers billions of pages of global content that includes historical newspapers, dissertations, and uniquely relevant resources for researchers of any age and sophistication—including content not likely to be digitized by others.
NIB1109.qxd 10/27/09 1:27 PM Page 2 10 Renal & Urology News NOVEMBER 2009 www.renalandurologynews.com Please visit us at www.renalandurologynews.com News in Brief Severe LUTS, Big CAC in Stage 3 Warfarin May Raise Stroke Waists Linked CKD Patients Risk in ESRD Patients study of 602 Korean men with A lower urinary tract symptoms (LUTS) secondary to benign prosta- C oronary artery calcification (CAC) is common among patients with W arfarin use in patients with both end-stage renal disease (ESRD) and atrial fibrillation are at increased risk for stroke, data suggest. It is not asso- tic hyperplasia found that those with stage 3 CKD, data show. Bryan R. ciated with increased all-cause mortality or hospitalization. a waist circumference greater than Kestenbaum, MD, of the University of Researchers followed 1,671 new ESRD patients with preexisting atrial fibril- 90 cm (central obesity) had a 36% Washington in Seattle, and colleagues lation for an average of 1.6 years from the time they started dialysis. Compared increased risk of severe LUTS com- studied 562 adult patients with CKD with nonuse, warfarin use was associated with a nearly twofold increased risk pared with men who had smaller (estimated glomerular filtration rate for a new stroke, investigators reported in the Journal of the American Society waists. In addition, in men with cen- [eGFR] of less than 60 mL/min/ of Nephrology (2009;20:2223-2233). Clopidogrel or aspirin use was not associ- tral obesity, prostate volume corre- 1.73 m2) and without clinical car- ated with the risk of a new stroke. lated positively with urgency and diovascular disease. The patients were The investigators concluded that “physicians should be cognizant of the pos- nocturia. Findings appear in the participants in the Multi-Ethnic Study sible risks associated with warfarin use for atrial fibrillation in patients with Asian Journal of Andrology (2009; of Atherosclerosis. Of the 562 subjects, ESRD, with careful evaluation of the risks and benefits of intervention at the published online ahead of print). n 98% had stage 3 CKD at baseline individual patient level.” n (median eGFR of 55.4). The study measured CAC at baseline and again Megestrol May approximately 1.6 or 3.2 years later. At baseline, 370 subjects (66%) had Emergency Departments Found Improve Weight CAC and 192 (34%) did not, accord- To Underuse MET for Stones ing to a report in Kidney International pilot study showed that mega- (2009;76:991-998). The prevalence edical expulsive therapy (MET) for urinary stones in American emer- A strol may help improve weight and the ability to exercise in dialy- was 24% lower in African Americans than in Caucasians after adjusting for M gency departments (ED) is underused despite evidence of its safety and efficacy, investigators have concluded. sis patients, according to a report in numerous potential confounders. CAC John M. Hollingsworth, MD, and colleagues at the University of Michigan in the Journal of Renal Nutrition (2009; developed in 39 (20%) who did not Ann Arbor analyzed 2000-2006 data from the National Hospital Ambulatory published online ahead of print). have it at baseline, for an estimated Medical Care Survey. They determined MET use by the prescription for a cal- Investigators randomized nine el- incidence of 8.5% per year. The inci-
Pages to are hidden for
"Niacinamide Helps Lower Phosphorus"Please download to view full document